An interview with the Pan-Arabian research Society of Gynecologic Oncology (PARSGO). 24 September 2025 Tell us about how PARSGO was started. PARSGO was founded in 2016 as a non-profit and non-political research organization in Berlin, Germany to address the unique challenges faced by women in the MENA and Sub-Saharan Africa regions concerning gynecologic cancers. […]
Read More >
An interview with the Nepal Cancer Relief Society (NCRS). 25 August 2025 Tell us about how NCRS was started. The then Shah royal princess, Jayanti Shah, witnessing the deaths of many family members due to heart disease, began working to help individualssuffering from heart conditions and to provide affordable heart treatment to the people of […]
Read More >
By Dr. Tracey Adams and Annwen Jones OBE, Co-Chairs, Global Expert Advisory Group on Ovarian Cancer 23 July 2025 Since our launch on World Ovarian Cancer Day in May, the Global Expert Advisory Group on Ovarian Cancer has issued a Statement of Intent and identified three priority areas for action that we believe will improve […]
Read More >
An interview with Tracy Milgram-Posner, Founder of BRCAStrong 23 July 2025 Tell us about how BRCAStrong was started. I found out I was BRCA-positive in my early twenties. I was young, otherwise healthy, and suddenly handed a reality that changed everything—my chances of developing breast or ovarian cancer were incredibly high. The doctors gave me […]
Read More >
By Annabel Deegan, Communications Advisor, World Ovarian Cancer Coalition 17 June 2025 It was a real privilege to attend The Economist Impact World Cancer Series Europe meeting in Brussels. This year’s conference was attended by a wide range of leaders in the global cancer community and the discussions focused on inclusive access to care and […]
Read More >
By Clara MacKay, CEO, World Ovarian Cancer Coalition It was great to be back in Chicago for this year’s American Society of Clinical Oncology (ASCO) meeting. A highlight of these meetings is always the opportunity to meet with leaders in the global cancer advocacy movement and 2025 did not disappoint! I was able to […]
Read More >
The June issue of the Journal of Cancer Policy includes the recent qualitative study with clinicians conducted as part of the multi-country observational Every Woman Study™ (EWS). Semi-structured interviews were conducted with clinicians between June 2022 and June 2023. The interview guide was developed by the EWS LMIC Oversight Committee, including patients, clinicians and data […]
Read More >
By Clara MacKay, CEO, World Ovarian Cancer Coalition 24 March 2025 The Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer is an important touchpoint for the entire community – clinicians, researchers, and those of us in advocacy. A key opportunity to learn about the latest advancements in gynecologic cancer treatment and research. With no […]
Read More >
2 February 2025 I had a great opportunity last week to showcase the Every Woman Study, low- and middle-income (LMIC) edition at the European Society for Gynaecologic Oncology Meeting in Rome, with a poster outlining potentially novel indicators for optimal cytoreductive surgery beyond age and stage of disease on diagnosis. Using data from 2446 women […]
Read More >
As I step into the role of Chair for the World Ovarian Cancer Coalition, I feel deeply honored and incredibly energized. The shoes I have to fill are significant, but I’ve had the privilege of learning from the best—Elizabeth Baugh and Annwen Jones OBE. Their leadership has shaped the Coalition into the impactful organization it […]
Read More >